Spyre Therapeutics, Inc.
SYRE
$14.43
$0.302.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 603.09M | 414.23M | 426.00M | 484.64M | 339.28M |
| Total Receivables | -- | 1.70M | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.39M | 5.15M | 9.74M | 2.63M | 2.25M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 608.47M | 421.08M | 435.74M | 487.27M | 341.53M |
|
|
|||||
| Total Current Assets | 608.47M | 421.08M | 435.74M | 487.27M | 341.53M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.00K | 10.00K | 331.00K | 329.00K | 331.00K |
| Total Assets | 608.48M | 421.09M | 436.07M | 487.60M | 341.86M |
|
|
|||||
| Total Accounts Payable | 666.00K | 5.17M | 3.23M | 3.11M | 896.00K |
| Total Accrued Expenses | 27.31M | 14.65M | 9.38M | 37.12M | 29.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 26.08M | 37.72M | 9.51M | 2.59M | 1.88M |
| Total Other Current Liabilities | 26.08M | 37.72M | 9.51M | 2.59M | 1.88M |
| Total Current Liabilities | 54.06M | 57.54M | 22.12M | 42.82M | 31.98M |
|
|
|||||
| Total Current Liabilities | 54.06M | 57.54M | 22.12M | 42.82M | 31.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 36.62M | 36.16M | 39.56M | 292.52M | 125.87M |
| Total Liabilities | 90.68M | 93.70M | 61.68M | 335.33M | 157.84M |
|
|
|||||
| Common Stock & APIC | 1.33B | 1.09B | 1.07B | 775.98M | 763.20M |
| Retained Earnings | -972.43M | -916.14M | -847.11M | -808.27M | -764.41M |
| Treasury Stock & Other | 180.00K | 1.46M | -553.00K | -363.00K | 302.00K |
| Total Common Equity | 361.98M | 171.57M | 218.57M | -32.66M | -911.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 155.82M | 155.82M | 155.82M | 184.93M | 184.93M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 155.82M | 155.82M | 155.82M | 184.93M | 184.93M |
|
|
|||||
| Total Common Equity | 361.98M | 171.57M | 218.57M | -32.66M | -911.00K |
| Total Preferred Equity | 155.82M | 155.82M | 155.82M | 184.93M | 184.93M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 517.80M | 327.39M | 374.39M | 152.27M | 184.02M |
|
|
|||||